Found: 13
Select item for more details and to access through your institution.
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. e164, doi. 10.1002/onco.13551
- By:
- Publication type:
- Article
Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 1, p. 16, doi. 10.1634/theoncologist.2018-0452
- By:
- Publication type:
- Article
A population pharmacokinetic/toxicity model for the reduction of platelets during a 48-h continuous intravenous infusion of the histone deacetylase inhibitor belinostat.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy.
- Published in:
- Cellular & Molecular Neurobiology, 2018, v. 38, n. 5, p. 1099, doi. 10.1007/s10571-018-0579-4
- By:
- Publication type:
- Article
A Phase II Multi-Center Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell Carcinoma.
- Published in:
- Oncologist, 2017, v. 22, n. 8, p. 888, doi. 10.1634/theoncologist.2017-0211
- By:
- Publication type:
- Article
Regulatory considerations on endpoints in ovarian cancer drug development.
- Published in:
- 2017
- By:
- Publication type:
- journal article
UGT1A1 genotype-dependent dose adjustment of belinostat in patients with advanced cancers using population pharmacokinetic modeling and simulation.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 4, p. 450, doi. 10.1002/jcph.627
- By:
- Publication type:
- Article
Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 4, p. 461, doi. 10.1002/jcph.625
- By:
- Publication type:
- Article
Phase II Clinical Trial of Ixabepilone in Metastatic Cervical Carcinoma.
- Published in:
- Oncologist, 2015, v. 20, n. 7, p. 725, doi. 10.1634/theoncologist.2015-0104
- By:
- Publication type:
- Article
The VEGF inhibitor axitinib has limited effectiveness as a therapy for adrenocortical cancer.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00261
- By:
- Publication type:
- Article
Association between benign thyroid and endocrine disorders and subsequent risk of thyroid cancer among 4.5 million U.S. male veterans.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Heterotopic Pregnancy Presenting as an Acute Abdomen: A Diagnostic Masquerader.
- Published in:
- 2000
- By:
- Publication type:
- Case Study